However, miRNAs validated by quantitative polymerase chain reaction (qPCR) (miR-4417 and miR-423-3p) could only discriminate hereditary (BRCA1, BRCA2, and BRCAX) from non-hereditary breast tumors (70.1% accuracy) [31]. The gene discussed is BRCA1; the disease is breast neoplasm.